IM Cannabis (IMCC) Cash & Equivalents (2019 - 2026)

IM Cannabis' Cash & Equivalents history runs 8 years deep, the most recent figure standing at $732122.5 for Q1 2026.

• In Q1 2026, Cash & Equivalents changed N/A year-over-year to $732122.5; the TTM figure through Mar 2026 stood at $732122.5 (changed N/A YoY), while the FY2025 annual figure was $2.0 million, up 210.23% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $732122.5, down from $2.0 million in the prior quarter.
• The five-year high for Cash & Equivalents was $8.1 million in Q1 2022, with the low at $511798.4 in Q2 2024.
• The 5-year median for Cash & Equivalents is $1.0 million (2023), against an average of $1.8 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 723.23% in 2022, then slumped 87.11% in 2023.
• IM Cannabis' Cash & Equivalents stood at $1.8 million in 2022, then fell by 26.19% to $1.3 million in 2023, then sank by 53.61% to $617777.8 in 2024, then jumped by 216.54% to $2.0 million in 2025, then tumbled by 62.56% to $732122.5 in 2026.
• Business Quant data shows IMCC's Cash & Equivalents at $732122.5 in Q1 2026, $2.0 million in Q4 2025, and $858882.6 in Q3 2025.